Aug. 26 (UPI) --The Food and Drug Administration on Monday approved Insulet's Omnipod 5 automated insulin delivery system for ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Automated insulin delivery (AID) systems reduce diabetes distress and fear of hypoglycemia, improve quality of life, and increase awareness about hypoglycemia in adults, children, and adolescents ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

She added, "We hope these case studies provide insights for health care professionals who assist athletes with type 1 diabetes using automated insulin delivery systems during intense physical ...

Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...

This growth will be mostly driven by insulin delivery devices ... MiniMed 600 series and 700 series pump systems. "Luna Diabetes trials automated wearable insulin pump" was originally created ...

Medtech companies have been working to create an automated insulin delivery system that requires minimal action from patients - and these integrations put both firms one step closer to this goal.

Insulet (Nasdaq:PODD) shares ticked up today on third-quarter results that came in well ahead of the consensus forecast.

Medscape Medical News, October 16, 2024 Automated Insulin Delivery Systems Reduce Burden in Diabetes Automated insulin delivery systems not only improved glycemic endpoints but also alleviated ...

Analysis - Pharmac's decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New ...